Dublin, March 28, 2018 -- The "Autoimmune Disease Diagnostic Market, Global Forecast, by Disease, by Regions and by Companies" report has been added to ResearchAndMarkets.com's offering.
Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period.
Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes misdirected and attacks the very organs it was designed to protect), thereby allowing the system tact up and attack healthy cells and tissues.
Autoimmune Disease Diagnostic Devices market is expected to witness substantial growth due to rising incidence of autoimmune diseases, Growing Rheumatoid Arthritis and technological advancements in diagnosis devices further boosts the demand for the industry over the forecast period.
The report studies the market of the following segments: [Systemic autoimmune disease diagnostics market (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE), others) and Localized autoimmune disease diagnostics Market.
By Disease:
It is a very common diagnosis that helps find immune diseases. With the rising incidence of autoimmune diseases in the several geographical regions and growing the number of Rheumatoid Arthritis, it is anticipated that the Autoimmune Disease Diagnostic market will grow in future.
By Test Type - Autoantibody Tests & CBC Tests have Bright Future
It is believed that in near future; Autoantibody Tests and Complete Blood Count Autoimmune Test will certainly rule the Autoimmune Disease Diagnostic Market. The report provides a detailed competitive landscaping Tests Market of Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C - reactive protein Tests, Urinalysis, Comprehensive Metabolic Panel and Others.
By Region - North America and Europe will drive the Autoimmune Disease Diagnostic Market
North America and Europe tend to have the considerable market in the Autoimmune Disease Diagnostic Market. In addition; the report also provides the complete geographical analysis of Asia-Pacific and Rest of World Autoimmune Disease Diagnostic Market.
Companies Analysis:
Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic and Bio-Rad Laboratories are some of the top companies operating in the global autoimmune disease diagnostic; which has been studied thoroughly in the report.
All the 7 Companies Studied in the Report have been Studied from 3 Points:
- Company Overview
- Business Strategy /Mergers & Acquisition
- Financial Insight
This report provides a complete analysis of the Autoimmune Disease Diagnostic Market, Growth Drivers, Challenges, and their projections for the upcoming years.
Autoimmune Disease Diagnostic Segments Covered in the Report:
Systemic autoimmune disease diagnostics market:
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Systemic Lupus Erythematosus (SLE)
- Others
Localized autoimmune disease diagnostics
Key Topics Covered:
1. Executive Summary
2. Global Autoimmune Diseases Diagnostic Market
3. Market Share - Global Autoimmune Diseases Diagnostic
3.1 By Disease - Global Autoimmune Diseases Diagnostic
3.2 By Disease - Systemic Autoimmune Diseases Diagnostic
3.3 By Region - Global Autoimmune Diseases Diagnostic
4. By Disease - Global Autoimmune Diseases Diagnostic Market
4.1 Systemic Autoimmune Disease
4.1.1 Rheumatoid Arthritis
4.1.2 Ankylosing Spondylitis
4.1.3 Systemic Lupus Erythematosus (SLE)
4.1.4 Others
4.2 Localized Autoimmune Disease Diagnostics
5. By Test Type - Global Autoimmune Diseases Diagnostic Market
5.1 Autoantibody Tests
5.2 Antinuclear Antibody (ANA) Tests
5.3 Complete Blood Count Tests
5.4 Erythrocyte Sedimentation Rate Tests
5.5 C-reactive protein (CRP) Tests
5.6 Urinalysis Tests
5.7 Comprehensive Metabolic Panel Tests
5.8 Others Tests
6. By Region - Global Autoimmune Diseases Diagnostic Market
7. Abbott Laboratories - Company Analysis
8. Siemens Healthineers - Company Analysis
9. Roche Diagnostics - Company Analysis
10. EUROIMMUN AG - Company Analysis
11. bioMerieux SA - Company Analysis
12. Quest Diagnostic - Company Analysis
13. Bio-Rad Laboratories - Company Analysis
14. Growth Drivers for Autoimmune Disease Diagnostic
15. Challenges for Autoimmune Disease Diagnostic
For more information about this report visit https://www.researchandmarkets.com/research/c6sqbt/autoimmune?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics


Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Apple Restores Telegram to App Store After Content Policy Violation
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Jetstar to Charge for Overhead Cabin Bags From February
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Telegram Restored on Apple App Store After Temporary Removal
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 



